Network origin in Kevan Cassidy first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Biotechnology | 10 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Kevan Cassidy via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Director/Board Member | |
Karolinska Institutet | College/University | Doctorate Degree | |
ALLIGATOR BIOSCIENCE AB | Biotechnology | Director/Board Member | |
University of Stockholm | College/University | Graduate Degree | |
Royal College of Surgeons | College/University | Undergraduate Degree | |
Umea Universitet | College/University | Undergraduate Degree | |
Intrexon ActoBiotics NV
Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium. | Biotechnology | Corporate Officer/Principal | |
Handelshögskolan i Göteborg | College/University | Graduate Degree | |
TikoMed AB
TikoMed AB Pharmaceuticals: MajorHealth Technology TikoMed AB is a Swedish pharmaceutical company that develops pharmaceutical products. The private company is based in Viken, Sweden. The company was founded by Adam Bruce, Lars Bruce. Anders Kristensson has been the CEO of the company since 2018. | Pharmaceuticals: Major | Chief Executive Officer | |
MIVAC Development AB
MIVAC Development AB BiotechnologyHealth Technology MIVAC Development AB develops treatment of autoimmune diseases and mucosal vaccine. The company was founded in 2008 and is headquartered in Goteborg, Sweden. | Biotechnology | Director/Board Member Chief Executive Officer | |
Anders Waas AB | Director/Board Member | ||
Juristfirma Louise Katsler Waas AB | Director/Board Member | ||
TOLERANZIA AB | Biotechnology | Director/Board Member | |
GABATHER AB | Pharmaceuticals: Major | Director of Finance/CFO | |
HOODIN AB | Packaged Software | Director/Board Member | |
Medlys HB | Corporate Officer/Principal | ||
Sahlgrenska University | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
F.A Management AB
F.A Management AB Miscellaneous Commercial ServicesCommercial Services F.A Management AB is a private company that provides corporate consulting services. The CEO of the Swedish company is Fredrik Andersson. | Miscellaneous Commercial Services | Chief Executive Officer | |
Sinfonia Biotherapeutics AB
Sinfonia Biotherapeutics AB BiotechnologyHealth Technology Sinfonia Biotherapeutics AB is a Swedish clinical stage company that develops biologics for neuropathic pain. The private company is based in Huddinge, Sweden. | Biotechnology | Director of Finance/CFO | |
Texray AB
Texray AB Packaged SoftwareTechnology Services Texray AB engages in development of medical technology products. It offers radiation protective textile. The company was founded by Petra Apell and Fredrik Gellerstedt and is headquartered in Göteborg, Sweden. | Packaged Software | Director/Board Member | |
Theradex (Europe) Ltd.
Theradex (Europe) Ltd. BiotechnologyHealth Technology Founded in 1992, Theradex (Europe) Ltd. is a subsidiary of Theradex Systems, Inc. that engages in research and experimental development on biotechnology. The company is based in Crawley, UK. | Biotechnology | Corporate Officer/Principal | |
Iscaff Pharma AB
Iscaff Pharma AB Miscellaneous Commercial ServicesCommercial Services Iscaff Pharma AB develops platform and drugs for treatment of cancer. It develops a scaffold technology for drug development and treatment of cancer. The firm's products and services include development support; 3D printed scaffolds; licensing of technologies; and diagnostics. The company was founded by Göran Landberg and Anders Torbjörn Ståhlberg and is headquartered in Gothenburg, Sweden. | Miscellaneous Commercial Services | Chairman | |
Transmed Gothenburg AB
Transmed Gothenburg AB Miscellaneous Commercial ServicesCommercial Services Transmed Gothenburg AB provides scientific and technical research and development services. The company is based in Gothenburg, Sweden. | Miscellaneous Commercial Services | Chairman | |
O Mgmt AB | Corporate Officer/Principal | ||
Inorbit Therapeutics AB
Inorbit Therapeutics AB Pharmaceuticals: MajorHealth Technology Inorbit Therapeutics AB discovers and develops small molecule therapeutics based on molecules with proven clinical efficacy in humans. The company was founded in 2015 and is headquartered in Moelndal, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Improve Tec Hönö AB | Chairman | ||
Sobrera Pharma AB
Sobrera Pharma AB Pharmaceuticals: MajorHealth Technology Sobrera Pharma AB is a Swedish pharmaceutical company that manufactures products for patients with alcohol use disorders. The company is based in Gothenburg, Sweden. The CEO of the company is Ann-Charlotte Rosendahl. | Pharmaceuticals: Major | Chairman | |
Sortina pharma AB
Sortina pharma AB Miscellaneous Commercial ServicesCommercial Services Sortina Pharma AB provides scientific and technical services. The company is based in Gothenburg, Sweden. The Swedish company was founded by Sara Rhost, Göran Landberg. | Miscellaneous Commercial Services | Chairman | |
Implexion Pharma AB
Implexion Pharma AB Miscellaneous Commercial ServicesCommercial Services Implexion Pharma AB is a Swedish company that focuses on researching and developing drugs. The company is based in Gothenburg, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
SiMSen Diagnostics AB
SiMSen Diagnostics AB Medical SpecialtiesHealth Technology SiMSen Diagnostics AB develops diagnostic substances. The company is based in Gothenburg, Sweden. | Medical Specialties | Director/Board Member | |
Uronauten AB | Director/Board Member | ||
Ivarsson Medical Research AB
Ivarsson Medical Research AB Investment Banks/BrokersFinance Ivarsson Medical Research AB is a Swedish company that engages in the management and trading of securities. The CEO of the private company is Marie-Lois Ivarsson. | Investment Banks/Brokers | Chief Executive Officer | |
Gudna Pharma AB | Director/Board Member | ||
Prorsum Trademark AB | Chairman | ||
Mercapri I Kungalv AB | Director/Board Member | ||
Prorsum Healthcare AB | Director/Board Member | ||
Huj Foods AB | Director/Board Member | ||
RGNT Electric AB
RGNT Electric AB Motor VehiclesConsumer Durables RGNT Electric AB is a Swedish company that specializes in electric motorcycles. The company is based in Kungsbacka, Sweden. The company's range of motorbikes is both timeless and forward-thinking. RGNT Electric was founded in 2019 by Jonathan Åström. Göran Karlsson has been the CEO of the company since January 12, 2023. | Motor Vehicles | Director/Board Member | |
SP HMSO Göteborg AB | Director/Board Member | ||
Link Medical Research AB
Link Medical Research AB Miscellaneous Commercial ServicesCommercial Services Part of Link Medical Research AS, Link Medical Research AB is a company that provides product development services for the pharmaceutical and medical device industries. The company is based in Solna, Sweden. The Swedish company was founded in 1995 by Ola Gudmundsen. Ola Gudmundsen has been the CEO since 1995. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Melius Pharma AB
Melius Pharma AB Pharmaceuticals: MajorHealth Technology Melius Pharma AB is a Swedish clinical stage pharmaceutical company that develops new treatments for chronic cough in idiopathic pulmonary fibrosis (IPF) patients. The company is based in Lund, Sweden and is privately owned, benefiting from the support of two of Sweden's most prominent professional life science investors who bring expertise to develop the company. IPF is a chronic, progressive lung inflammation characterized by fibrosis and disruption of normal lung architecture. Melius Pharma has developed ME-015, which stabilizes ion channels in the neuronal endings in the lungs that mediate cough. ME-015 is presumed to have an acute effect and is a solution for chronic cough, which is one of the major symptoms experienced by 80%% of IPF patients. | Pharmaceuticals: Major | Director of Finance/CFO | |
Lennart ekerholms stiftelse | Investment Trusts/Mutual Funds | Director/Board Member | |
OligoNova Accelerate AB | Chairman | ||
SENSIDOSE AB | Electronic Equipment/Instruments | Director of Finance/CFO | |
ALZINOVA AB | Pharmaceuticals: Major | Director/Board Member | |
BIOEXTRAX AB | Biotechnology | Director of Finance/CFO |
Statistics
International
Sweden | 45 |
United States | 2 |
Norway | 2 |
Ireland | 2 |
Belgium | 2 |
Sectoral
Health Technology | 19 |
Consumer Services | 7 |
Commercial Services | 7 |
Technology Services | 3 |
Finance | 2 |
Operational
Director/Board Member | 32 |
Chairman | 11 |
Independent Dir/Board Member | 10 |
Corporate Officer/Principal | 9 |
Chief Executive Officer | 6 |
Most connected contacts
- Stock Market
- Insiders
- Kevan Cassidy
- Company connections